The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mandelia Ashish since 2020.
This trader's CIK number is 1782805.
At the time of last reporting, Mandelia Ashish was the VP, Chief Accounting Officer of Mersana Therapeutics, Inc.. (stock ticker symbol MRSN).
Also see all insider trading activities at Mersana Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | MRSN | 0 | $0 | 6,352 | $3,853 | 16,114 | $0 |
| 2024 | MRSN | 0 | $0 | 13,241 | $29,914 | 42,780 | $0 |
| 2023 | MRSN | 0 | $0 | 3,575 | $20,520 | 10,136 | $0 |
| 2022 | MRSN | 0 | $0 | 1,982 | $11,733 | 5,353 | $0 |
| 2021 | MRSN | 0 | $0 | 1,734 | $31,017 | 834 | $0 |
| 2020 | MRSN | 3,383 | $16,475 | 3,383 | $76,083 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-15 | MRSN | Option Ex | 8,685 | .00 | 0 |
| 2025-01-16 | MRSN | Sale | 3,554 | .58 | 2,061 |
| 2025-01-14 | MRSN | Option Ex | 4,783 | .00 | 0 |
| 2025-01-15 | MRSN | Sale | 1,791 | .63 | 1,128 |
| 2025-01-13 | MRSN | Option Ex | 2,646 | .00 | 0 |
| 2025-01-14 | MRSN | Sale | 1,007 | .66 | 664 |
| 2024-10-01 | MRSN | Option Ex | 30,000 | .00 | 0 |
| 2024-10-03 | MRSN | Sale | 3,361 | 1.96 | 6,587 |
| 2024-10-02 | MRSN | Sale | 4,855 | 2.00 | 9,710 |
| 2024-01-16 | MRSN | Sale | 5,025 | 2.71 | 13,617 |
| 2024-01-13 | MRSN | Option Ex | 2,645 | .00 | 0 |
| 2024-01-14 | MRSN | Option Ex | 4,783 | .00 | 0 |
| 2024-01-15 | MRSN | Option Ex | 5,352 | .00 | 0 |
| 2023-01-14 | MRSN | Option Ex | 4,784 | .00 | 0 |
| 2023-01-15 | MRSN | Option Ex | 5,352 | .00 | 0 |
| 2023-01-17 | MRSN | Sale | 3,575 | 5.74 | 20,520 |
| 2022-01-14 | MRSN | Option Ex | 5,353 | .00 | 0 |
| 2022-01-18 | MRSN | Sale | 1,982 | 5.92 | 11,733 |
| 2021-07-01 | MRSN | Sale | 942 | 13.60 | 12,811 |
| 2021-01-19 | MRSN | Sale | 545 | 21.28 | 11,597 |
| 2021-01-15 | MRSN | Option Ex | 834 | .00 | 0 |
| 2021-01-04 | MRSN | Sale | 247 | 26.76 | 6,609 |
| 2020-06-30 | MRSN | Buy | 3,383 | 4.87 | 16,475 |
| 2020-07-02 | MRSN | Sale | 3,383 | 22.49 | 76,083 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mandelia Ashish (VP, Chief Accounting Officer of Mersana Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.